These covariates include; adherence to treatment, development of drug toxicity in the form of peripheral neuropathy and lactic acidosis, change in treatment therapy, gender, age, CD4 baseline and viral load baseline and resistance to treatment on transition intensities are assessed. This evidence concerns the gene CD4 and peripheral neuropathy.